Public Benefit Corporation
Status: concept — incorporated as a Delaware PBC in 2026.
PRISM operates as a Public Benefit Corporation so that its commitment to patient outcomes is a charter-level legal obligation, not a mission statement. The structure exists for one reason: to make mission drift as hard as the law allows, in a company whose technology must never be turned against the patients it screens.
Why a benefit corporation
A conventional corporation's directors owe their duty to shareholder value; everything else is discretionary. A Delaware PBC changes the duty itself. The charter names a specific public benefit — improving patient health outcomes through earlier detection of medical conditions — and directors are legally required to weigh that benefit alongside financial return in their decisions. Choices that favor patients over short-term profit are not acts of managerial generosity that a future board could discontinue; they are what the governing documents demand.
The binding survives changes of control. The public benefit lives in the certificate of incorporation, so it persists through new investors, new management, new owners, and the departure of the founder. Removing it would require amending the charter itself — a deliberate, visible, stockholder-level act — not a quiet strategy shift. Anyone who acquires PRISM acquires the obligation with it.
That durability matters because the plausible failure mode for PRISM is specific and foreseeable. A system that reads claims histories and learns utilization phenotypes sits uncomfortably close to technologies that could ration or deny care. The charter is one of two locks against that repurposing; the other is built into the software itself.
Two locks, one purpose
Mission-drift protection does not rest on the charter alone. The constructive-only architecture enforces the same commitment mechanically: the system counts positive suggestions only, and no pathway exists to emit a denial, a risk score against a patient, or a "no need to test." Silence is never reported as clearance — it is simply the absence of a flag (see recall, not prediction).
| lock | nature | what it prevents | fails if |
|---|---|---|---|
| PBC charter | legal | governance decisions that subordinate patient benefit to profit | the charter is amended by stockholder vote |
| Constructive-only architecture | technical | the deployed system emitting any care-restricting output | the software is deliberately rebuilt |
The two locks are independent — neither depends on the other holding. Subverting the mission would require both a formal legal amendment and an intentional re-engineering of the system, two separate acts by two separate mechanisms, each visible. No single decision, owner, or pressure defeats both at once.
Why not a nonprofit
A nonprofit charter would bind the mission at least as tightly, but it cannot fund the deployment. Production PRISM is infrastructure-heavy: racks of GPUs installed on insurer premises, continuous retraining, engineering staff, and long validation periods before the first dollar of results-based revenue arrives. Philanthropic funding rarely arrives at that scale or on that timeline, and grant cycles are a poor match for multi-year infrastructure buildout. The PBC form keeps the mission in the charter while leaving equity investment — the funding instrument that actually fits this cost structure — fully available.
Why investors still fit
The PBC form only works if investors have a genuine reason to accept the dual mandate, and here they do: the public benefit is the economic engine. Under results-based compensation, PRISM earns nothing unless a suggestion leads to a documented early detection — and each genuine early detection averts the downstream treatment costs of a late one, which is where the payer's savings and PRISM's share both come from. There is no version of this business that profits without patients benefiting first; the charter obligation and the revenue mechanism point the same direction. Investors are buying the upside of a system that only gets paid for being right, with the legal structure removing the temptation to make money any other way.
The PBC form does not, by itself, make the technology work — the synthetic prototype carries that burden, and real-data validation is still ahead. What the structure guarantees is narrower and worth stating plainly: whatever PRISM becomes, it is bound to become it in service of the benefit written into its charter.
PRISM is currently a solo-built effort; for the project's identity, contact points, and team framing, see the project.
See also
- Constructive-only architecture — the technical half of the mission lock
- Results-based compensation — why revenue only exists when patients benefit
- The project — PBC identity, founder, and contact